Rocket Pharmaceuticals, Inc.
RCKT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $363,722 | $271,998 | $734,323 | $1,225,953 |
| - Cash | $75,948 | $32,819 | $49,810 | $163,635 |
| + Debt | $25,045 | $25,202 | $25,352 | $25,498 |
| Enterprise Value | $312,819 | $264,381 | $709,865 | $1,087,816 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$46,619 | -$65,867 | -$57,873 | -$57,493 |
| % Margin | – | – | – | – |
| Net Income | -$50,332 | -$68,919 | -$61,334 | -$60,327 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.45 | -0.62 | -0.56 | -0.62 |
| % Growth | 27.4% | -10.7% | 9.7% | – |
| Operating Cash Flow | -$50,428 | -$48,964 | -$55,802 | -$46,957 |
| Capital Expenditures | $54 | -$50 | -$364 | -$309 |
| Free Cash Flow | -$50,374 | -$49,014 | -$56,166 | -$47,266 |